Sildenafil Administration to Treat Neonatal Encephalopathy

NCT02812433 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Neonatal Encephalopathy

Interventions

DRUG: Sildenafil
DRUG: Ora-Blend

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre